BRCA1/2 and other predisposition genes in high-risk hormone receptor+/human epidermal growth factor receptor 2- breast cancer treated with endocrine therapy with or without palbociclib: a secondary PENELOPE-B study analysis : original reports : biomarkers - Hahnen, Eric Thomas; Hauke, Jan; Gelmon, Karen; Marmé, Frederik; Ernst, Corinna; Martin, Miguel; Untch, Michael; Bonnefoi, Hervé; Knudsen, Erik; Im, Seock-Ah; DeMichele, Angela; Van't Veer, Laura; et al. (JCO precision oncology, 2025)
Gesehen am 10.06.2025